Breaking News, Collaborations & Alliances

Charles River, Transposagen in Rat Pact

Charles River Laboratories has entered into an exclusive, long-term marketing and distribution agreement with Transposagen Biopharmaceuticals, Inc., a KY-based provider of genetically modified rat models.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Charles River Laboratories has entered into an exclusive, long-term marketing and distribution agreement with Transposagen Biopharmaceuticals, Inc., a KY-based provider of genetically modified rat models. Charles River will be the exclusive, global provider for Transposagen’s p53 and Bcrp TGEM Knockout Rat Models and associated downstream services. The companies have also entered a R&D collaboration under which scientific management from both companies will work towards the creation of selec...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters